We’re not finding what you’re searching for. Click below to send us an email and our customer support team will help you find what you’re looking for.
If you are currently being treated for osteoporosis with Prolia, the February 2023 issue of the Journal of the American Board of Family Medicine contained
At the beginning of this year, The American College of Physicians (ACP) updated its guidelines for therapy to reduce the risk of fractures in adults
Prolia® (generic name: denosumab) is prescribed for patients in danger of developing osteoporosis, usually due to the normal aging process that causes changes in bone
Prolia® (generic name: denosumab) is a recently developed drug prescribed for a wide range of conditions of the skeletal bones, including osteoporosis, bone loss induced
